Answer
A later donor stem-cell transplant may carry an increased risk of severe complications, including graft-versus-host disease. The transplant team must know about previous mogamulizumab exposure.
Sources for this answer
- Poteligeo 4 mg/mL, Concentrate for Solution for Infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.